DAIC

JUNE 19, 2024

Cingolani, director of Cardiogenetics and Preclinical Research in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, is exploring new ways to help patients with ventricular tachycardia (VT), a recurring, abnormally fast and irregular heartbeat that starts in the lower chambers, or ventricles, of the heart.

Tachycardia 128

Tachycardia Cardiac Arrest Ablation Research 128

HCPLive

NOVEMBER 16, 2024

Initial catheter ablation achieved a lower risk of a composite primary endpoint event than anti-arrhythmic drug therapy in patients who survived a heart attack.

Ablation 52

Ablation Heart attacks Heart Attack Tachycardia 52

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 trial showed. Death or.

Tachycardia 98

Tachycardia Heart Attack Heart attacks Ablation 98

CardiacWire

NOVEMBER 20, 2024

Late-breaking results from the VANISH2 trial presented at AHA 2024 showed that catheter ablation might be a better first-line treatment than antiarrhythmic drugs for ventricular tachycardia patients with ischemic cardiomyopathy. Over a median of 4.3 Over a median of 4.3

Ablation 59

Ablation Tachycardia Cardiomyopathy Heart Attack 59